OM:ASKERHealthcare
Asker Healthcare Group (OM:ASKER) Stock Faces Rich Valuation As EPS Growth Reinforces Bullish Narratives
Asker Healthcare Group (OM:ASKER) has put solid numbers on the table for Q2 2026, with revenue of SEK4.7b and basic EPS of SEK0.57 alongside net income of SEK219m. On a trailing twelve month basis, EPS stands at SEK1.92 on revenue of SEK18.0b and net income of SEK684m. The company has seen quarterly revenue move from SEK4.0b in Q2 2025 to SEK4.7b in Q2 2026, with basic EPS shifting from SEK0.34 to SEK0.57 over the same period. Trailing net profit margin sits at 3.8% versus 2.7% a year...